Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNASDAQ:PGNYNASDAQ:SHCRNASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$112.16+0.6%$102.28$88.96▼$136.72$2.06B0.85167,317 shs181,565 shsPGNYProgyny$20.52-1.8%$22.15$13.39▼$30.42$1.76B1.371.71 million shs822,500 shsSHCRSharecare$1.43$1.43$0.48▼$1.44$531.79M0.512.55 million shsN/AWGSGeneDx$71.60+6.3%$84.79$19.49▼$117.75$2.04B1.96767,026 shs660,629 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+0.56%+0.47%+13.45%+2.68%+1.71%PGNYProgyny-1.77%-7.98%-8.09%-11.55%-23.26%SHCRSharecare0.00%0.00%0.00%0.00%+65.95%WGSGeneDx+6.34%+4.82%-32.25%-25.28%+258.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.7868 of 5 stars3.63.00.05.02.72.52.5PGNYProgyny1.5163 of 5 stars2.21.00.00.03.51.71.3SHCRSharecareN/AN/AN/AN/AN/AN/AN/AN/AWGSGeneDx3.2964 of 5 stars2.42.00.00.04.15.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5727.11% UpsidePGNYProgyny 2.42Hold$23.4514.30% UpsideSHCRSharecare 2.00Hold$1.43N/AWGSGeneDx 2.75Moderate Buy$86.7521.16% UpsideCurrent Analyst Ratings BreakdownLatest SHCR, ADUS, WGS, and PGNY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.005/1/2025WGSGeneDxTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$135.00 ➝ $110.005/1/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/10/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.003/31/2025PGNYProgynyBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$28.003/12/2025ADUSAddus HomeCareStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$142.00 ➝ $142.002/28/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$17.00 ➝ $23.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.21B1.70$5.18 per share21.65$43.58 per share2.57PGNYProgyny$1.21B1.45$0.58 per share35.58$5.77 per share3.56SHCRSharecare$445.25M1.19N/AN/A$1.22 per share1.17WGSGeneDx$330.14M6.19N/AN/A$8.78 per share8.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$62.52M$4.4325.6720.931.416.50%9.62%7.37%8/4/2025 (Estimated)PGNYProgyny$62.04M$0.5735.3831.572.395.03%11.36%7.87%8/5/2025 (Estimated)SHCRSharecare-$128.50M-$0.39N/AN/AN/A-33.64%-22.81%-15.96%N/AWGSGeneDx-$175.77M-$1.41N/A34.26N/A-17.12%3.33%1.69%7/29/2025 (Estimated)Latest SHCR, ADUS, WGS, and PGNY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 million4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 million2/24/2025Q4 2024ADUSAddus HomeCare$1.35$1.26-$0.09$1.07$291.04 million$297.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ASHCRSharecareN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCareN/A2.112.11PGNYProgynyN/A2.622.62SHCRSharecareN/A2.022.02WGSGeneDx0.252.402.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%PGNYProgyny94.93%SHCRSharecare35.08%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%PGNYProgyny9.40%SHCRSharecare30.61%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare33,20018.40 million17.30 millionOptionablePGNYProgyny31085.72 million74.68 millionOptionableSHCRSharecare3,352371.88 million258.05 millionOptionableWGSGeneDx1,20028.53 million19.97 millionOptionableSHCR, ADUS, WGS, and PGNY HeadlinesRecent News About These CompaniesPalisades Investment Partners LLC Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 24 at 6:53 AM | marketbeat.com61,710 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Purchased by Castleark Management LLCMay 24 at 6:05 AM | marketbeat.comPharVision Advisers LLC Buys Shares of 3,910 GeneDx Holdings Corp. (NASDAQ:WGS)May 24 at 5:32 AM | marketbeat.comGeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at ScaleMay 22 at 9:30 PM | finance.yahoo.comGeneDx to Participate in Upcoming Investor ConferencesMay 22 at 4:05 PM | businesswire.comPoint72 Asset Management L.P. Sells 230,583 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)May 22 at 4:42 AM | marketbeat.comSoleus Capital Management L.P. Invests $307,000 in GeneDx Holdings Corp. (NASDAQ:WGS)May 21 at 8:13 AM | marketbeat.comSilvercrest Asset Management Group LLC Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 21 at 5:42 AM | marketbeat.comGeneDx: Strong Fundamentals Intact As Market Misreads Test Volume DipMay 20, 2025 | seekingalpha.com13,100 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Polar Asset Management Partners Inc.May 20, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Summit Partners Public Asset Management LLCMay 19, 2025 | marketbeat.comRedwood Investment Management LLC Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS)May 19, 2025 | marketbeat.comEnsign Peak Advisors Inc Acquires Shares of 26,900 GeneDx Holdings Corp. (NASDAQ:WGS)May 18, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Holdings Lifted by Northern Trust CorpMay 18, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Trading Up 5.8% - Here's What HappenedMay 18, 2025 | americanbankingnews.comDimensional Fund Advisors LP Takes $1.08 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 18, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Earns Buy Rating from Analysts at GuggenheimMay 18, 2025 | americanbankingnews.comBNP Paribas Financial Markets Purchases Shares of 56,588 GeneDx Holdings Corp. (NASDAQ:WGS)May 17, 2025 | marketbeat.comTreehouse Foods, GeneDx Holdings See Activist ActionMay 16, 2025 | msn.comPanoramic Capital LLC Purchases Shares of 51,294 GeneDx Holdings Corp. (NASDAQ:WGS)May 16, 2025 | marketbeat.comNia Impact Advisors LLC Invests $1.48 Million in GeneDx Holdings Corp. (NASDAQ:WGS)May 16, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSHCR, ADUS, WGS, and PGNY Company DescriptionsAddus HomeCare NASDAQ:ADUS$112.16 +0.63 (+0.56%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$112.22 +0.06 (+0.05%) As of 05/23/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Progyny NASDAQ:PGNY$20.52 -0.37 (-1.77%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$20.51 -0.01 (-0.05%) As of 05/23/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Sharecare NASDAQ:SHCRSharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.GeneDx NASDAQ:WGS$71.60 +4.27 (+6.34%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$70.94 -0.66 (-0.92%) As of 05/23/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
